Imperial and UbiPharm have announced the formation of a strategic alliance, in the hope of creating one of the most expansive healthcare distribution networks on the continent.
This strategic alliance hopes to provide complementary continental route-to-market solutions to healthcare principals and clients, leveraging best-in-class operations and commercial services.
While Imperial and UbiPharm will each maintain their individual business autonomies, the strategic alliance looks to drive better access to medicines, vaccines and other healthcare products for patients and consumers across 40 African countries, representing one of the most expansive networks for healthcare distribution on the continent. All the activities essential to the availability of medicines – including manufacturing, regulatory, promotion and distribution – will be readily available to healthcare principals through this network.
Mohammed Akoojee, Group CEO of Imperial commented: “This strategic alliance with UbiPharm is in line with this ambition and our ‘Gateway to Africa’ strategy, which is also focused on expanding our geographic footprint and reach on the African continent, including in Francophone and Lusophone African countries. A Pan-African solution such as this one bodes well for our principals, clients and customers and, more importantly, enhances healthcare through increased patient access to vital medicines that are critical for sustainable development of the African continent”.
The alliance between Imperial and UbiPharm aims to meet the growing demand from the healthcare industry for a global, secure, and efficient continental solution in Anglophone, Francophone, and Lusophone Africa countries, in compliance with Good Distribution Practices (GDP).
Gérard Mangoua, Group CEO of UbiPharm, adds “UbiPharm is a socially responsible company that, for 30 years, has pursued the same mission: to promote access to health solutions in the regions where we operate, particularly French-speaking Africa. Our alliance with Imperial is aligned with our strategy, which is to continuously innovate to meet the changing needs of populations. This alliance will make it possible to strengthen access to health solutions on the African continent”.
Source: Imperial
